|
|
Volumn 2, Issue 1, 2001, Pages 33-38
|
|
The pharma sector and its financing in Belgium
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FIBRIC ACID DERIVATIVE;
HISTAMINE H2 RECEPTOR ANTAGONIST;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PROTON PUMP INHIBITOR;
ARTICLE;
BELGIUM;
CALCULATION;
CONTROLLED STUDY;
DRUG CLASSIFICATION;
DRUG COST;
EUROPE;
FINANCIAL MANAGEMENT;
GOVERNMENT;
HEALTH CARE;
HEALTH CARE POLICY;
HEALTH ECONOMICS;
HOSPITAL;
PHARMACY;
PRESCRIPTION;
PRIORITY JOURNAL;
SELF CARE;
|
|
EID: 0034750637
PISSN: 14393972
EISSN: None
Source Type: Journal
DOI: 10.1007/pl00012217 Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
